BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25477880)

  • 21. Antitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches.
    Horn T; Grab J; Schusdziarra J; Schmid S; Maurer T; Nawroth R; Wolf P; Pritsch M; Gschwend JE; Kübler HR; Beckhove P
    Int J Cancer; 2013 Nov; 133(9):2145-56. PubMed ID: 23625723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4(+) T-cell responses.
    Liu J; Cao S; Peppers G; Kim SH; Graham BS
    Eur J Immunol; 2014 Apr; 44(4):1058-68. PubMed ID: 24510524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose metabolism regulates T cell activation, differentiation, and functions.
    Palmer CS; Ostrowski M; Balderson B; Christian N; Crowe SM
    Front Immunol; 2015; 6():1. PubMed ID: 25657648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD26: a negative selection marker for human Treg cells.
    Salgado FJ; Pérez-Díaz A; Villanueva NM; Lamas O; Arias P; Nogueira M
    Cytometry A; 2012 Oct; 81(10):843-55. PubMed ID: 22949266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory T cells form stable and long-lasting cell cluster with myeloid dendritic cells (DC).
    Herman S; Krenbek D; Klimas M; Bonelli M; Steiner CW; Pietschmann P; Smolen JS; Scheinecker C
    Int Immunol; 2012 Jul; 24(7):417-26. PubMed ID: 22366044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage.
    Koyama K; Kagamu H; Miura S; Hiura T; Miyabayashi T; Itoh R; Kuriyama H; Tanaka H; Tanaka J; Yoshizawa H; Nakata K; Gejyo F
    Clin Cancer Res; 2008 Nov; 14(21):6770-9. PubMed ID: 18980970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiatherogenic effect of pioglitazone on uremic apolipoprotein E knockout mice by modulation of the balance of regulatory and effector T cells.
    Shen Y; Yuan Z; Yin A; Liu Y; Xiao Y; Wu Y; Wang L; Liang X; Zhao Y; Tian Y; Liu W; Chen T; Kishimoto C
    Atherosclerosis; 2011 Oct; 218(2):330-8. PubMed ID: 21868013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity.
    Levings MK; Allan S; d'Hennezel E; Piccirillo CA
    Adv Immunol; 2006; 92():119-55. PubMed ID: 17145303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism in Immune Cell Differentiation and Function.
    Chapman NM; Shrestha S; Chi H
    Adv Exp Med Biol; 2017; 1011():1-85. PubMed ID: 28875486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early effector cells survive the contraction phase in malaria infection and generate both central and effector memory T cells.
    Opata MM; Carpio VH; Ibitokou SA; Dillon BE; Obiero JM; Stephens R
    J Immunol; 2015 Jun; 194(11):5346-54. PubMed ID: 25911759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antileukemic T-cell responses can be predicted by the composition of specific regulatory T-cell subpopulations.
    Schick J; Vogt V; Zerwes M; Kroell T; Kraemer D; Köhne CH; Hausmann A; Buhmann R; Tischer J; Schmetzer H
    J Immunother; 2013 May; 36(4):223-37. PubMed ID: 23603857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor 2 enhances regulatory T-cell functions and suppresses food allergy in an experimental model.
    Yang G; Geng XR; Song JP; Wu Y; Yan H; Zhan Z; Yang L; He W; Liu ZQ; Qiu S; Liu Z; Yang PC
    J Allergy Clin Immunol; 2014 Jun; 133(6):1702-8.e5. PubMed ID: 24698315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aging disturbs the balance between effector and regulatory CD4+ T cells.
    van der Geest KS; Abdulahad WH; Tete SM; Lorencetti PG; Horst G; Bos NA; Kroesen BJ; Brouwer E; Boots AM
    Exp Gerontol; 2014 Dec; 60():190-6. PubMed ID: 25449852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental plasticity of murine and human Foxp3(+) regulatory T cells.
    Liston A; Piccirillo CA
    Adv Immunol; 2013; 119():85-106. PubMed ID: 23886065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial Control and Guidance of Cellular Activities of T Cells.
    Chao T; Wang H; Ho PC
    Front Immunol; 2017; 8():473. PubMed ID: 28484465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells.
    Crellin NK; Garcia RV; Levings MK
    J Immunol Methods; 2007 Jul; 324(1-2):92-104. PubMed ID: 17582431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression.
    Mercadante ER; Lorenz UM
    Front Immunol; 2016; 7():193. PubMed ID: 27242798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micro-inflammation characterized by disturbed Treg/Teff balance with increasing sIL-2R in patients with type 2 diabetes.
    Cai B; Zhang J; Zhang M; Li L; Feng W; An Z; Wang L
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):214-9. PubMed ID: 23595796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic drives affecting Th17/Treg gene expression changes and differentiation: impact on immune-microenvironment regulation.
    Brescia C; Audia S; Pugliano A; Scaglione F; Iuliano R; Trapasso F; Perrotti N; Chiarella E; Amato R
    APMIS; 2024 Jan; ():. PubMed ID: 38239016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.